Cortex Innovation

[Khadijah Khaliq @khadijahkq5]

Check out my latest blog post 'ICE-T Congress Reflection'! As I discuss my experiences at the conference as a pre-medicine undergraduate student new to learning about immune cell effector therapy. Read more: https://t.co/Cd4lpWEn7v @Cortex_Innov @NausheenAhmedMD

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

From a one-room home shared with cattle…
to the world’s biggest scientific stage. 🌍🏆

This year’s #NobelPrize in Chemistry Omar Yaghi was born in Amman, Jordan 🇯🇴 in 1965 to parents who were refugees from Palestine 🇵🇸

Today, that same boy shares the 2025 Nobel Prize in Chemistry 🧪 with Susumu Kitagawa 🇯🇵 and Richard Robson 🇦🇺

Their groundbreaking work on metal–organic frameworks is transforming clean energy, water purification, and carbon capture. 🌱

“Science is the greatest equalising force in the world.
Smart, talented people exist everywhere — we just need to give them the opportunity.” 💡

— Prof. Omar Yaghi

@NobelPrize

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

2/USMIRC- Cortex Medal 2025 (Mentorship Award): Forat Lutfi, MD

#ICE_T #mmsm #MedEd #myeloma #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما @CancerNetwrk @kucancercenter @Cortex_Innov

[Cortex Innovation @Cortex_Innov]

Dr Sayeef Mirza from @MoffittNews presents at #ICE_TCongress25 on CARt in lymphoma. Day 2 starts strong !

[USMIRC News @USMIRCNEWS]

Interactive learning in Session 3! Participants engaged in a real-time Immune Effector Cell Toxicity Simulation, gaining hands-on experience to improve patient care.

#ICE_T #mmsm #MedEd #myeloma #MedTwitter #USMIRC
@USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما
@CancerNetwrk #leukemia @oncodaily #lymphoma
#CARTCell @KUcancercenter

[USMIRC News @USMIRCNEWS]

The Program Infrastructure and Development Workshop at ICE-T Congress 2025 offered participants an inside look at CAR-T manufacturing and GMP process development. #ICE_T #mmsm #MedEd #myeloma #MedTwitter #USMIRC
@USMIRCNEWS
@OncoAlert
#سرطان_الدم #المايلوما
@CancerNetwrk
#leukemia
@oncodaily
#lymphoma #CARTCell
@KUcancercenter

[Nausheen Ahmed MD @NausheenAhmedMD]

#ICE_TCongress25. Dr McGuirk describes the past, present and future of #CAR_T @KUcancercenter @Abdallah81MD

[Nausheen Ahmed MD @NausheenAhmedMD]

@Abdallah81MD with opening statements for #ICE_TCongress25 . The turnout this early in the morning is phenomenal ! Hoping for a fun day ! @KUcancercenter

[Nausheen Ahmed MD @NausheenAhmedMD]

Warming up for #ICE_T_Congress in #KC at the reception with Dr Al Rajabi, Dr Baranda @KUcancercenter @Abdallah81MD

[Nausheen Ahmed MD @NausheenAhmedMD]

📣Our letter “#REMS to #Reach” is out. . @BilalAbidMD. 🌟🌟In our view (personal opinion), the modification of REMS is more than just a regulatory change—it is a catalyst for democratizing access, reducing delivery costs and patient burden, academic-community-industry collaboration, and innovation across the #CAR_T #ecosystem.🌟🌟

🙋🏻‍♀️Which model of CART care delivery do you see being predominant in the next 5 years??? 👇👇

https://t.co/oDXi4sx096

[OncoDaily @oncodaily]

Through Every Challenge, They’ve Been My Strength - Al-Ola A Abdallah
@Abdallah81MD

https://t.co/a5UQP8so23

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

[Cortex Innovation @Cortex_Innov]

🎉🚀 The #ICET Conference is live in Orlando, FL! 🌞 Explore #myeloma, #lymphoma, #leukemia & #solidTumors. Discover the latest in bispecifics, CAR-T, & T cell engagers! 🧬✨ Learn how to bring these to your clinic. #ICET2025

[Muhammad Atif Khan MD MS FACP @atif_khanktk]

Just out: key safety reporting patterns for TCEs in multiple myeloma
@faiza_HKhan @NausheenAhmedMD @Abdallah81MD @KUcancercenter @kczmj @Cortex_Innov #hemeonc

https://t.co/HUQjbRpiQI

[Benlazar S M A @smbenlazar]

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management https://t.co/CZjw2wDeRy #AML #leusm

[Nausheen Ahmed MD @NausheenAhmedMD]

ICE-T: Where immune cell therapy meets bold ideas, real talk, and the people actually doing the work.
Don’t just hear about it—be there.
Whether you're in the clinic or the classroom, ICE-T delivers practical updates for nurses, APPs, and physicians in both community and academic settings.

🗓️ Date: Saturday, July 26, 2025
📍 Location: Signia by Hilton Bonnet Creek, Orlando, FL
🎤 Format: Interactive talks, panels & networking

✅ View Agenda & Speakers: https://t.co/gwzJVkgVIO
✅ Register Now: https://t.co/zBg2I07PQU

🌞 Bring your questions, your curiosity, and your sunscreen—we can’t wait to see you there!
📩 Questions? Contact us: [email protected]
🔗 Learn more: https://t.co/ni60JXDN8L

#CellTherapy #Oncology #ICET2025 #NursesInOncology #APPs #CommunityOncology #AcademicMedicine #FLASCO #CORTEX

[Nausheen Ahmed MD @NausheenAhmedMD]

This is a major win for patients . we have been advocating this with our publications on access ! Finally - REMS is revised and product labeling revision to include 2 weeks monitoring and driving restriction and not 4 weeks. 👍🏼

-monitor patients for at least 2 wk, with daily monitoring for 1 wk
- stay within vicinity of ATC for 2 weeks
- avoid driving for 2 weeks ( no more 8 weeks ) @wwesson24 @hhashmi87 @Abdallah81MD @kczmj

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🚨 Major congratulations! 🚨

Dr. Joseph McGuirk, Division Director of Hematologic Malignancies & Cellular Therapeutics, has been awarded the prestigious 2025 KCU Alumni Lifetime Achievement Award!

A true pioneer in CAR T therapy and Malignant Hematology — well deserved! 👏🎉 #KUcancer #KCUalumni #CART @KUcancercenter @OncoAlert #MedEd #MedTwitter @Larvol @USMIRCNEWS @medicalwatchBC

[Faiz Anwer MD @FaizAnwerMD1]

Global access to novel MM therapies remains challenging, barriers and suggested strategies to bridge the gap.

Global Access to Multiple Myeloma Therapies | JCO Global Oncology https://t.co/j38oJiTjtG

[Prerna Mewawalla @myelomadoctor]

📢 Excited to share our multicenter study just published in Clinical Lymphoma, Myeloma & Leukemia:

“Real-world outcomes of sequential BCMA therapies in RRMM after belantamab”

🔗 https://t.co/gtXbyhk9a7

Shout-out to @hhashmi87 @dileo63
With: Yue Yin Christopher Strouse @hiragss
James David Omar Alkharabsheh AliyaRashid
@NausheenAhmedMD @Abdallah81MD

#MMSM #BCMA #CART #Bispecifics #Belantamab #USMIRC @AHNIMres

[Nausheen Ahmed MD @NausheenAhmedMD]

Excellent discussion. Audience questions mostly future of #CART, where will it be used in next decade and scope with non cancer diseases
@KUcancercenter #HemOncReview @Oncn @Abdallah81MD @md_anusha @AYACOUB7